Cardax Stock News

Cardax (OTCMKTS: CDXI) is one of 909 publicly-traded companies in the “Pharmaceutical preparations” industry, but how does it compare to its peers? We will compare Cardax to similar businesses based on the strength of its valuation, analyst recommendations, risk, dividends, earnings, profitability and institutional ownership. Volatility & Risk Cardax has a beta of 1.02, meaning […] The post Analyzing Cardax (CDXI) and Its Rivals appeared first on ETF Daily News .

InflaRx (NASDAQ:IFRX) and Cardax (OTCMKTS:CDXI) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, risk, earnings, analyst recommendations, valuation, institutional ownership and profitability. Analyst Recommendations This is a breakdown of recent recommendations and price targets for InflaRx and Cardax, as []

Cardax, Inc. (OTCMKTS:CDXI)s stock price rose 44.4% during mid-day trading on Thursday . The company traded as high as $0.65 and last traded at $0.65. Approximately 100 shares were traded during trading, a decline of 81% from the average daily volume of 532 shares. The stock had previously closed at $0.45. The firms 50 day []

Shares of Cardax, Inc. (OTCMKTS:CDXI) traded up 44.4% on Thursday . The company traded as high as $0.65 and last traded at $0.65. 100 shares traded hands during mid-day trading, a decline of 81% from the average session volume of 532 shares. The stock had previously closed at $0.45. The firms fifty day moving average []